Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Dutch (AEX) Market Analysis & Valuation

UpdatedFeb 08, 2026
DataAggregated Company Financials
Companies99
  • 7D-0.5%
  • 3M12.3%
  • 1Y23.6%
  • YTD6.8%

In the last week, the market has stayed flat, however the Materials sector stood out, gaining 8.0%. Meanwhile, the market is actually up 24% over the past year. Looking forward, earnings are forecast to grow by 13% annually.

Market Valuation and Performance

Has the Dutch Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 09 Feb 2026€1.3t€539.6b€57.1b17.2x22.2x2.3x
Wed, 07 Jan 2026€1.2t€541.0b€54.8b16.9x21.7x2.2x
Fri, 05 Dec 2025€1.1t€533.2b€54.2b16.8x20.4x2.1x
Sun, 02 Nov 2025€1.1t€532.4b€53.7b17x20.8x2.1x
Tue, 30 Sep 2025€1.1t€534.7b€52.9b16.9x20.4x2x
Thu, 28 Aug 2025€1.0t€549.5b€66.8b16.8x15.3x1.9x
Sat, 26 Jul 2025€1.0t€543.7b€62.5b18.9x16.3x1.9x
Mon, 23 Jun 2025€1.0t€543.4b€58.3b18x17.4x1.9x
Wed, 21 May 2025€1.0t€544.3b€58.5b19.2x17.8x1.9x
Fri, 18 Apr 2025€926.7b€543.5b€58.2b15.6x15.9x1.7x
Sun, 16 Mar 2025€1.0t€567.4b€58.1b18.3x17.5x1.8x
Tue, 11 Feb 2025€1.0t€572.9b€57.9b17x17.9x1.8x
Thu, 09 Jan 2025€996.5b€563.5b€51.7b16.3x19.3x1.8x
Sat, 07 Dec 2024€1.0t€561.8b€51.5b17.4x19.4x1.8x
Mon, 04 Nov 2024€974.1b€560.5b€51.1b17.6x19.1x1.7x
Wed, 02 Oct 2024€1.0t€560.9b€52.6b17.5x19.8x1.9x
Fri, 30 Aug 2024€1.1t€566.9b€40.1b16.5x26.5x1.9x
Sun, 28 Jul 2024€1.0t€561.6b€41.5b16.5x25x1.8x
Tue, 25 Jun 2024€1.1t€562.4b€44.6b17.3x25x2x
Thu, 23 May 2024€1.1t€561.7b€44.5b17.4x24.6x2x
Sat, 20 Apr 2024€1.0t€565.9b€45.2b16.3x22.4x1.8x
Mon, 18 Mar 2024€1.0t€547.1b€46.3b15.9x21.6x1.8x
Wed, 14 Feb 2024€992.6b€568.7b€49.7b16x20x1.7x
Fri, 12 Jan 2024€897.3b€590.1b€60.1b16.1x14.9x1.5x
Sun, 10 Dec 2023€902.7b€598.3b€60.5b15.7x14.9x1.5x
Tue, 07 Nov 2023€833.5b€602.1b€60.2b15.6x13.9x1.4x
Thu, 05 Oct 2023€818.8b€593.3b€50.5b15.9x16.2x1.4x
Sat, 02 Sep 2023€908.7b€580.8b€49.2b17.2x18.5x1.6x
Mon, 31 Jul 2023€946.1b€580.1b€53.8b16.7x17.6x1.6x
Wed, 28 Jun 2023€892.7b€583.4b€48.0b16.9x18.6x1.5x
Fri, 26 May 2023€895.4b€576.6b€47.7b17.1x18.8x1.6x
Sun, 23 Apr 2023€881.1b€575.8b€49.7b17.2x17.7x1.5x
Tue, 21 Mar 2023€731.6b€547.3b€44.8b15.6x16.3x1.3x
Thu, 16 Feb 2023€910.2b€543.0b€49.9b15.3x18.3x1.7x
Price to Earnings Ratio

18.3x


Total Market Cap: €910.2bTotal Earnings: €49.9bTotal Revenue: €543.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Dutch Market Price to Earnings3Y Average 19.3x202420252026
Current Market PE
  • Investors are optimistic on the Dutch market, and appear confident in strong long term growth rates.
  • The market is trading at a PE ratio of 22.2x which is higher than its 3-year average PE of 19.3x.
Past Earnings Growth
  • The earnings for Dutch listed companies have grown 4.7% per year over the last three years, while revenues have remained steady.
  • This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.

Sector Trends

Which sectors have driven the changes within the Dutch Market?

NL Market-0.49%
Materials7.98%
Consumer Staples5.77%
Real Estate1.64%
Healthcare1.42%
Utilities0%0
Energy-0.34%
Telecom-1.02%
Industrials-1.12%
Financials-1.45%
Tech-1.88%
Consumer Discretionary-4.98%
Sector PE
  • Investors favour the Tech sector the most for future growth, which is trading above its 3-year average PE ratio of 38.7x.
    • Analysts are expecting annual earnings growth of 16.0%, which is lower than the prior year's growth of 26.9% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare sector, expecting annual earnings growth of 30% over the next 5 years.
  • In contrast, the Telecom industry is expected to see its earnings growth to stay flat over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
MT ArcelorMittal€51.2011.4%
+€4.0b		87.1%PE14.6xMaterials
HEIA Heineken€73.686.3%
+€2.4b		8.5%PE22.4xConsumer Staples
CCEP Coca-Cola Europacific Partners€81.406.3%
+€1.8b		5.3%PE23.8xConsumer Staples
AD Koninklijke Ahold Delhaize€34.966.1%
+€1.8b		-0.5%PE15xConsumer Staples
INGA ING Groep€25.352.1%
+€1.5b		58.7%PB1.5xFinancials
See more

Market Insights

Header cover image
Why alternative investments are making a splash 🖼️
Richard Bowman avatar
Richard Bowman
|
|
Is it the time to invest in alternatives? Here's how you can get exposure.
Continue reading
Why longer lifespans could reshape portfolios 🧓
Last Week

Why longer lifespans could reshape portfolios 🧓

Latest News

INGA
€25.35
ING Groep
7D
2.1%
1Y
58.7%

INGA: Future Returns Will Depend On Execution Of Earnings And Cash Distribution Plans

Our fair value estimate for ING Groep has shifted from €24.69 to €26.39, with analysts pointing to recent price target increases and rating upgrades that reflect their views on volume growth prospects, profitability, and updated P/E expectations. Analyst Commentary Recent Street research on ING Groep has been active, with several firms updating views on the shares.
WKL
€67.70
Wolters Kluwer
7D
-14.2%
1Y
-61.7%

WKL: AI Selloff And New Buy Rating May Support Future Upside

Analysts have made a small trim to their Wolters Kluwer price target, reflecting a slightly higher discount rate and largely unchanged assumptions on revenue growth, profit margins and future P/E. Recent research ranges from a new Buy initiation at €125 to a reduced neutral target of €105.
MT
€51.20
ArcelorMittal
7D
11.4%
1Y
87.1%

MT: Steel Cycle Resilience And Asset Moves Will Support Balanced Returns

Analysts have raised their price target for ArcelorMittal to approximately €47 from about €43, citing updated assumptions that include an improved profit margin outlook and a slightly lower future P/E multiple. These changes are partially offset by more cautious revenue growth expectations and a modestly higher discount rate.
PHARM
€1.37
Pharming Group
7D
-20.2%
1Y
64.5%
ASML
€1,193.80
ASML Holding
7D
-1.8%
1Y
69.8%

ASML: Frothy Repricing Could Unravel If Wafer Fab Spending Disappoints

Analysts have lifted their fair value estimate for ASML Holding by about €274 to €1,003, reflecting updated assumptions for revenue growth, profitability and future P/E after a wave of recent price target increases from major banks and brokers. Analyst Commentary Recent research on ASML has been highly active, with a cluster of fresh price targets and rating changes pointing to a wide range of views on how much upside is already reflected in the share price.
HEIO
€66.40
Heineken Holding
7D
6.6%
1Y
12.3%

HEIO: Future Returns Will Rely On Stable Margins And Undervalued Earnings Multiple

Analysts now keep their price target for Heineken Holding steady at €107.00, citing unchanged assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E as the key reasons for maintaining their view. Valuation Changes Fair Value: kept unchanged at €107.00, indicating no adjustment to the central valuation estimate.
AD
€34.96
Koninklijke Ahold Delhaize
7D
6.1%
1Y
-0.5%

AD: Margin Stability And Share Buybacks Will Shape Future Price Re Rating

Analysts have made a slight downward adjustment to their fair value estimate for Koninklijke Ahold Delhaize, reflecting a modest trim in the overall price target. This change balances a higher assumed discount rate with updated views on revenue growth, margins, and future P/E expectations, alongside mixed recent Street targets ranging from about €24.60 to €41.
UMG
€19.71
Universal Music Group
7D
-4.7%
1Y
-27.0%
CVC
€12.97
CVC Capital Partners
7D
-13.1%
1Y
-43.1%
ASM
€683.80
ASM International
7D
-3.7%
1Y
25.3%

ASM: Premium Margins And Almere Expansion Will Support Future Share Performance

The updated analyst price target for ASM International moves to €745.05 from €627.47, reflecting analysts' recent target hikes from multiple banks and their rationale around modestly adjusted growth, slightly higher margins and a higher assumed future P/E of about 39.6x. Analyst Commentary Recent Street research on ASM International shows a mix of optimism on long term opportunities alongside fresh caution around where the shares are currently trading and how expectations are set.
KPN
€4.48
Koninklijke KPN
7D
9.0%
1Y
26.8%

Koninklijke KPN (AMS:KPN) Is Increasing Its Dividend To €0.109

Jan 31
Koninklijke KPN (AMS:KPN) Is Increasing Its Dividend To €0.109
HEIA
€73.68
Heineken
7D
6.3%
1Y
8.5%
PRX
€46.00
Prosus
7D
-5.1%
1Y
18.3%

PRX: Buybacks And Cash Returns Will Narrow The Holding Discount

Analysts have recently nudged their price targets for Prosus higher, with one moving to €74 from €69, another adjusting to €69 from €68.50, and a third changing to €72 from €75. These revisions reflect updated views on discount rates, revenue growth, profit margins and future P/E assumptions.
CCEP
€81.40
Coca-Cola Europacific Partners
7D
6.3%
1Y
5.3%

CCEP: Dividend And Buybacks Will Offset Execution And Sentiment Risks

Our fair value estimate for Coca-Cola Europacific Partners has increased by $1 to $77, as analysts incorporate slightly stronger revenue growth, a modestly higher profit margin, and a marginally lower future P/E multiple in their updated price targets and recent research. Analyst Commentary Recent Street research on Coca-Cola Europacific Partners has shown a mix of views, with some banks lifting their targets while others trimming expectations or turning more cautious on the shares.
ADYEN
€1,134.80
Adyen
7D
-9.5%
1Y
-26.9%

ADYEN: Market Share Gains And Cost Discipline Will Support Balanced Outlook

Adyen's updated analyst price target edges higher as fair value is revised to €1,361.98, supported by slightly adjusted revenue growth and margin assumptions. This is reinforced by recent target increases and rating upgrades from analysts.
DSFIR
€70.52
DSM-Firmenich
7D
6.5%
1Y
-26.1%

DSFIR: Market Share Defense Will Counter Rising European Commoditization Risk

The analyst fair value estimate for DSM-Firmenich has been reduced from €100.20 to €96.62, as analysts factor in lower assumed revenue growth and profit margins, slightly higher discount rates, and recent Street research highlighting full valuation, limited EBITDA growth prospects in 2026, and rising commoditization risks in European consumer ingredients. Analyst Commentary Recent Street research on DSM-Firmenich points to a more balanced view of the shares, with several firms trimming price targets and some shifting to more neutral stances.